Shayne Heffernan, Economist and Excogitator

Every financial revolution has changed the speed and the surface of finance without changing its substance. Debt cycles still overshoot. Inflation still compounds. Bubbles still form around the new thing while the old rules keep applying. What is different this time is that intelligence itself has become abundant, and everything abundant gets cheap. The scarce thing now is a distinct human presence: judgement shaped by real consequence, taste built over decades, and the willingness to care about a question for longer than is efficient.

I write about that gap most days, and I build in it the rest of the time. Forty years across capital markets, venture capital and emerging technology, and the part that still cannot be automated is the judgement about which question was worth asking. Everything below is published at Live Trading News, wrapped in post-quantum cryptography and anchored on chain at the moment it goes out. The text cannot be altered. Change a word and it is re-signed and re-stamped, and the chain records the new time, so every version and every date stands permanently on the record.

AI

The build-out, the quantum timeline, and what any of it is actually for.

Thinking

Judgement, independence, and staying non-fungible in an AI world.

Markets

Stocks, macro, ramblings and the KXCO build.

Longevity

Healthspan science, and separating the evidence from the sales pitch.

Life

Food, travel, sport, and the unoptimised parts that refill the well.

Latest

3 November 2026

KXCO's FDA Ontology Ranked INO-3107 First. Inovio Hit Over 300% After Hours.

KXCO's FDA ontology ranked INO-3107, from Inovio (INO), first of the FDA decisions due in the next 90 days, from 21 October 2026 to the decision. The FDA granted accelerated approval on 30 October; the news reached the market after the close. From its $0.60 close that day, Inovio traded as high as $2.71 after hours, up 351.7%, and closed 2 November at $1.89, up 215.0%. Both published research books closed ahead of XBI. On our radar: BBP-418 (BBIO), Bezuclastinib (COGT) and Relutrigine (PRAX).

1 November 2026

AI Stocks, Week of 1 November 2026: Seven Buys and the Ontology Behind Them

Shayne Heffernan rates seven AI stocks buys for the week of 1 November 2026: Nvidia, Broadcom, TSMC, Microsoft, Oracle, Palantir and ASML. The latest results put the contracted backlog of the four largest cloud sellers at about $2.48 trillion, and Amazon, Alphabet, Microsoft and Meta plan about $720 billion to $740 billion of capital spending in 2026. Every call links to KXCO's AI ontology, updated on 1 November with the quarter's results, power and grid data and new defence contracts.

31 October 2026

KXCO's FDA Ontology Ranked INO-3107 First. The FDA Approved It.

From 21 to 30 October 2026, the first screen of KXCO's FDA ontology at kxco.ai/fda ranked Inovio's INO-3107 #1 in the next 90 days by potential return, at +112% on the first day and +103% from 22 October on its own sourced inputs. On 30 October the FDA granted it accelerated approval, on its target date. The room's watch flagged the approval that night, and the record took in the FDA's own letter 19 minutes later.

31 October 2026

AI Is Not Overvalued. It Is Underestimated.

Markets debate whether artificial intelligence (AI) is overvalued. Shayne Heffernan argues the more material risk is underestimation. Alphabet's capital expenditure reached $51.4 billion in the third quarter, Google Cloud revenue rose 103% to $30.7 billion and the Cloud backlog stands at $561 billion, per its 28 October results and earnings call. Jurisdictions that block data centres do not remove the demand: they import the capability later, at a higher price.

30 October 2026

Binance: No Evidence of a Key Leak in a $6.3bn Hack. Control What Keys Sign

Binance estimates that about $6.3 billion was taken from it on 29 October 2026, and it found no evidence of any wallet private key leak. TRM Labs found Binance wallets on chain after chain produced valid signatures for the attacker within about half an hour. A valid signature proves a key signed, not that anyone with authority meant it to. Here are five controls, one for each of the attack's four reported steps and one for the trace, in post-quantum cryptography.